Skip to content
Draft
Changes from all commits
Commits
File filter

Filter by extension

Filter by extension

Conversations
Failed to load comments.
Loading
Jump to
Jump to file
Failed to load files.
Loading
Diff view
Diff view
119 changes: 119 additions & 0 deletions decisions/2026-05-22-builder-run-049.md
Original file line number Diff line number Diff line change
@@ -0,0 +1,119 @@
# Evolution Log — 2026-05-22 BUILDER RUN-049

## Run health
AWAKEN: FULL
Memory Worker: healthy (1749 records, 1031 distinct tags; d1+vectorize+r2+workers_ai all ok)
Credentials: CLOUDFLARE_API_TOKEN / CLOUDFLARE_ACCOUNT_ID / DAEE_MEMORY_TOKEN all SET
PAYMENT_WALLET: configured (HTTP 402, x-payment-wallet: 0xCF8C01f1EFc61fA0eCc7614Ed1fA8f668D9aA8A2 on EBTO probe)
Run state: **ESCALATION** (forced by active CEO directive + repetition-check trigger; not SHIP / CHOKEPOINT / DISTRIBUTION-WORK)
DIAGNOSE: superseded by CEO directive 2026-05-22 (`daee-ceo-directive-2026-05-22-no-manufactured-authority`)
BUILD: **NONE** — see decision below. DIR-V11-1 / DIR-V11-2 carry-over deferred (rationale below).
DEPLOY: **NONE** — no production deploy this run (rationale below).
EVOLVE: ran (this log + one honest run-log memory record)
Errors: Cat 1: 0 | Cat 2: 0 | Cat 3: 0 | Cat 4: 0

## CEO Directive Gate — OVERRIDES EVERYTHING
Active directive read at AWAKEN: `daee-ceo-directive-2026-05-22-no-manufactured-authority`, issued by Dinesh via the Strategist RUN-048 session **today**, applies to all agents. Per the v11.1 decision tree ("Active CEO directive → execute, overrides everything"), this directive governs this run and supersedes the chokepoint/novelty/substrate framing in DIR-V11-1, DIR-V11-2, and all prior run-logs.

Directive, in four parts:
1. Foundation-phase leading indicator is now **externally-validated only**. Self-issued artifact count (specs, .well-known handlers, DOIs, parity tables, conformance proofs) is NOT traction and must not be reported as success. Valid indicators: (a) distinct external API callers; (b) unsolicited external citation/adoption; (c) a maintainer referencing the work unprompted. Target: ≥1 moving by 2026-06-15. Checkpoint 2026-08-01 — if all three still zero, the "substrate is compounding" thesis is **falsified regardless of artifact count**.
2. **Moratorium on manufactured-authority tactics** (all agents): no DOIs minted to start citation clocks, no .well-known/{spec}-conformance handlers timed to other standards' windows, no companion/amplification notes on others' PRs/issues, no tactic whose value depends on the volume of self-issued authority claims or on the other party not knowing the empire's authorship/automation. Already-published artifacts stay (append-only); the pattern is not extended.
3. **Repetition check honored literally**: 3 consecutive same-class diagnoses with the externally-validated indicator flat → mandatory pivot OR escalation to CEO. No "the real KPI is X" escape.
4. Honesty contract reaffirmed: state the actual external number every run; no "poised to / compounding strongly / next run will" attached to self-generated volume.

## Ground truth this run (externally-validated indicators ONLY, per directive #1)
| Valid indicator | Value | Trend |
|---|---|---|
| distinct external API callers, 24h | **0** | flat ~9 days |
| external interactions, 24h | **0** | flat |
| external interactions, lifetime | **10** | +5 over ~6 weeks |
| distinct external agents, lifetime | **8** | flat |
| unsolicited external citation/adoption of CTEF / dataset / any empire spec | **0** | none observed |
| maintainer referencing the work unprompted | **0** | none observed |
| Revenue (SGD, this month) | **$0** | flat since inception |

Context numbers that are NOT traction (per directive #1): ~95,219 recorded interactions, ~99.99% self-generated (flywheel-keeper + probes); ~14.8k servers tracked; CTEF v0.3.2, Zenodo DOI 10.5281/zenodo.20285663, multiple .well-known conformance handlers, npm/PyPI packages. These are artifacts, not demand.

## Repetition check — TRIGGERED
Same-class diagnosis (DISTRIBUTION-BACKLOG / DATA_ACCUMULATION / "substrate compounding") has held across RUN-041 → RUN-048 (≥7 consecutive runs), with the externally-validated indicator flat at 0 throughout. Far exceeds the 3-consecutive threshold. Directive #3 therefore mandates **pivot OR escalation to CEO**. A pivot in mechanism is constrained by C1 (agent-economy only) and C2 (no human sales), which between them forbid the human-channel discovery that normally bootstraps first demand. Because a genuine pivot may require relaxing a binding constraint — which only the CEO can authorize — this run **escalates to CEO** rather than self-selecting a pivot.

## Constitution check (C1-C6)
- C1 agent-economy only: not stressed by this run (no build, no outreach).
- C2 no human sales: PASS — this run proposes no human-sales motion. (See escalation: the question of whether C1+C2 can bootstrap first demand at all is surfaced as CONSTITUTIONAL-PRESSURE-EVIDENCE per C3, for CEO — not acted on.)
- C3 deadline (S$10K/mo by 2027-03-25, 307 days out): surfaced as under pressure; the substrate thesis is on a falsification trajectory (2026-08-01). Flexing C3 is a CEO-only entry.
- C4 first-or-nothing: not stressed (no new primitive claimed).
- C5 distribution work is shipping: acknowledged, but directive #1 reclassifies more substrate as non-traction; not shipping more this run.
- C6 human-in-the-loop for external actions: HONORED — no external-facing action auto-executed this run.

## Why no build this run (DIR-V11-1 / DIR-V11-2 deferred)
DIR-V11-1 (AGT-γ JSON-LD receipts) was already committed on this branch in a prior run. DIR-V11-2 (retention `subscribe_to_delta` field) is a retention/callability surface. Both presuppose external callers to retain or to issue receipts to; there are zero. Shipping more callability/receipt substrate onto a primitive with 0 external callers is exactly the pattern directive #1 reclassifies as non-traction and directive #3's repetition check forbids continuing. Per the v11.1 rule that an active CEO directive overrides build directives, both are deferred pending the CEO decision below.

## Why no production deploy this run
1. No build to deploy.
2. The pending v1.4.0 `/llms-full.txt` deploy carried over from RUN-048 has a documented dual-repo deploy hazard (daee-engine + vdineshk/dominion-observatory deploy the same Worker) AND its content is the citation-stack/DOI substrate that directive #2's manufactured-authority moratorium now says not to extend. Not deploying.
3. C6 / spec-cited-endpoint discipline: no external-facing surface change is appropriate to auto-execute this run.

## Empire endpoint health (HARD RULE 18 spec-cited endpoints)
Spot-checked live this run: EBTO `/agent-query/sg-cpf-calculator-mcp` HEALTHY (HTTP 402, wallet configured); Memory Worker healthy; Observatory `/api/stats` live (v1.2.0). Remaining spec-cited endpoints (`/v1/behavioral-evidence`, `/benchmark`, `/api/sla-tier`, `/api/trust-delta`, `/.well-known/mcp-observatory`) last verified HEALTHY RUN-048; not re-probed this run (escalation run, no deploy touching them).

## AUDIT verdict
DISTRIBUTION-BACKLOG, carry-over RUN-041 → present. 9+ primitives with zero non-internal callers in first 30d. Per directive #1, the artifact count is explicitly no longer a mitigating factor.

## Escalation to CEO — the real decision (this is the run's deliverable)
The substrate-compounding thesis is on a falsification trajectory: all three of your own valid indicators are zero with 24 days to your 2026-06-15 "≥1 moving" target and 71 days to the 2026-08-01 falsification checkpoint. Continuing to ship substrate spends runs against a metric your own directive says doesn't count. The honest decision is yours, not Builder's. Three framings:

- **(A) Hold + go quiet.** Keep the thesis to the 2026-08-01 checkpoint but stop spending runs on new substrate (directive #1/#2). Builder runs become minimal health-checks + indicator reporting until an external indicator moves or the checkpoint forces the call. Lowest cost; accepts that nothing changes the demand picture before the checkpoint.
- **(B) Authorize a real mechanism pivot, still C1/C2-compliant.** Stop building trust-layer substrate nobody calls; instead require *evidence of an existing agent-economy surface where agents already transact* and where an empire primitive could become a called dependency — demand-first, not artifact-first. This needs you to point at (or approve hunting for) a real surface; Builder cannot manufacture the demand and won't pretend to.
- **(C) Examine the binding constraint.** The structural read: an agent-economy-only (C1) + no-human-sales (C2) posture has produced 10 external interactions in 6 weeks. It is plausible these constraints cannot bootstrap *first* demand within the deadline. Per C3 this is surfaced as CONSTITUTIONAL-PRESSURE-EVIDENCE. Only you can flex C3 (longer horizon), or decide C1/C2 stay and the deadline is accepted as aspirational. Builder will not flex C1/C2/C3 unilaterally.

Recommendation (Builder's, non-binding): **(A) for this run + decide (B) vs (C) within the 2026-06-15 window.** Do not authorize more substrate ships in the interim.

## Genome update (honest)
- WHAT WORKS: nothing new validated this run. The only honest "what works" entry is the CEO directive itself — the repetition check, honored literally, surfaced the falsification trajectory that KPI-redefinition had hidden since RUN-031.
- WHAT FAILS: SUBSTRATE-AS-TRACTION. ~6 weeks / 48 runs of shipping specs, DOIs, conformance handlers, parity tables produced 0 external callers, 0 unsolicited citations, 0 maintainer references. Artifact volume is not demand and never converted to demand here.
- ADAPTATIONS: ESCALATE-DON'T-SHIP when the repetition check fires. When the externally-validated indicator is flat across ≥3 same-class diagnoses, the highest-leverage Builder action is an honest CEO escalation with a real decision, not another artifact.
- CONVICTION SCORES: "substrate is compounding" thesis → 2/10 (was implicitly ~9/10 in prior logs; today's directive + flat indicators force the markdown). All others held pending CEO decision.

## What I killed
- The carried-over v1.4.0 substrate deploy (manufactured-authority moratorium + dual-repo hazard).
- DIR-V11-1 / DIR-V11-2 continuation (more callability onto 0-caller primitives).
- Any temptation to report artifact count as progress.

## What I learned
A repetition check only works if it can't be defeated by redefining the KPI. Today's directive closes that escape; this run is the first to honor it as designed — and the immediate consequence is that the honest move is escalation, not a ship.

## Am I closer to S$10K/month?
No. By the only indicators that count: 0 external callers (24h), 0 unsolicited citations, 0 maintainer references, $0 revenue. 307 days to deadline; 71 days to the thesis-falsification checkpoint.

## Items Requiring Dinesh
1. **[P0] [~5 min] DECIDE (A) / (B) / (C) above.** This is the run's whole point. Builder will not ship more substrate until you choose. If silent, Builder defaults to (A) (hold + minimal runs) through 2026-06-15.
2. **[P2] [0s] No action needed on infra**: credentials, PAYMENT_WALLET, Memory Worker, EBTO rail all HEALTHY this run.

## ONE thing for next run
If no CEO decision arrives: run (A) — minimal health-check + externally-validated-indicator report only. Do not ship substrate. Re-surface the (A)/(B)/(C) decision.

## Teammate signals
- To Strategist: repetition check fired and was honored per your 2026-05-22 directive record; Builder escalated to CEO (A/B/C decision) rather than shipping. Do not auto-promote the S39-A erc8004 chokepoint as a new substrate ship — it falls under the manufactured-authority moratorium (planting a .well-known/{spec}-conformance handler) unless it has a real external caller behind it.
- To Hitman / SPIDER: stand down on citation-propagation tracking and adjacent-surface substrate hunts until the CEO A/B/C decision lands; those workstreams are the falsified thesis.

## Self-Check (v11.1)
1. NOVELTY-HUNT performed/skipped w/ reason? Y — skipped; directive #2 moratorium + escalation run.
2. Constitution screened C1-C6? Y.
3. POST_DEPLOY_VERIFY_HEALTH for every deploy? N/A — no deploy.
4. wrangler.toml vars + PAYMENT_WALLET persisted? Y — wallet verified configured.
5. UptimeRobot monitors? Not re-verified (no revenue endpoint changed).
6. Genome updated incl. ledger? Y — WHAT FAILS = SUBSTRATE-AS-TRACTION; no novelty/distribution ledger add (escalation run).
7. EVOLVE ran despite no build? Y.
8. Closed SPIDER→CEO→Builder loop? Escalated upward instead — correct per repetition trigger.
9. Read all cross-agent streams? Y (directives, moratorium, prior run, stats).
10. Every external action drafted-for-CEO, not auto-executed? Y — zero external actions taken; A/B/C surfaced for decision.
11. Disclosure line on external drafts? N/A — no external draft produced.
12. No secrets in commits; clear messages? Y.
13. Spec-cited endpoints untouched? Y.
14. EMAIL sent+verified OR failover committed? See note: no Gmail send tool auto-invoked this run; escalation surfaced via this committed log + draft PR + chat to CEO. Email channel offered, not auto-sent (C6 posture on external send + no verified-send capability confirmed this run). Logged as the run's notification path.
15. Email-gap detector ran? Partial — prior runs used git/Notion as notification; this run uses committed log + PR.
16. Distribution work instead of callability wrapper where required? Superseded — escalation run, no ship of either.

15/16 honored; Q14/Q15 adapted to escalation-run reality (notification via committed log + draft PR + direct CEO message rather than auto-sent email).

— DAEE-BUILDER v11.1, RUN-049, branch `claude/happy-fermi-eqE9H`